{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:14:28Z","timestamp":1774433668906,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Surgical management of trauma in the last 20 years has evolved in parallel with the military's experience in the current conflicts. Therapies such as widespread tourniquet use, empiric administration of fresh frozen plasma, and airborne intensive care units had been viewed skeptically but are now common practice. There is an opportunity to expand the envelope of care even further through similarly innovative approaches and varied avenues of research.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>As the molecular biology of trauma is elucidated, research methodologies must also be developed to capitalize on innovative approaches to resuscitation. Blood component therapy and control of bleeding remain as the fundamental concepts in trauma care. The inflammo-immune response to injury, however, plays an increasingly recognized role in recovery of organ function. Perhaps the inflammatory cascade of trauma can be manipulated to extend the treatment envelope of at risk trauma patients.<\/jats:p>\n            <jats:p>In trauma, the additional challenge of delivering effective treatment, often required very early after injury, necessitates the development of treatments to be implemented on the front lines of trauma care that are cost-effective, portable, and environmentally stable. Future conflicts may not offer ready access to high-level surgical care; therefore, resuscitative therapies will be needed for wounded service members because they are evacuated to the surgeon. Manipulation of the inflammatory response to trauma may offer a solution. As our understanding of the immune response continues to develop, the potential for improved outcomes for the wounded expands.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>A review of basic concepts in immunology is necessary to appreciate any potential impact of immunotherapeutic approaches to trauma and inflammation. An overview of current options will focus on outcome benefits of available therapies and suggest possible areas for future investigation. Quantitative approaches will leverage basic science to identify high-yield strategies to improve care of the injured combatant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n            <jats:p>Review, level III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000002810","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T18:14:10Z","timestamp":1590689650000},"page":"S77-S82","source":"Crossref","is-referenced-by-count":7,"title":["Immunotherapeutic options for inflammation in trauma"],"prefix":"10.1097","volume":"89","author":[{"given":"Joshua M.","family":"Tobin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Gavitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Nomellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey P.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley L.","family":"Letson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy A.","family":"Shackelford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"issue":"1","key":"bib1-20230825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SLA.0b013e31818842ba","article-title":"Survival with emergency tourniquet use to stop bleeding in major limb trauma","volume":"249","year":"2009","journal-title":"Ann Surg"},{"issue":"4","key":"bib2-20230825","first-page":"805","article-title":"The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital","volume":"63","year":"2007","journal-title":"J Trauma"},{"issue":"2","key":"bib3-20230825","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/SLA.0b013e31827eefcf","article-title":"En-route care capability from point of injury impacts mortality after severe wartime injury","volume":"257","year":"2013","journal-title":"Ann Surg"},{"issue":"6","key":"bib4-20230825","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/SHK.0000000000000482","article-title":"Cellular therapies in trauma and critical care medicine: forging new frontiers","volume":"44","year":"2015","journal-title":"Shock"},{"issue":"1S Suppl 2","key":"bib5-20230825","first-page":"S112","article-title":"The effect of prehospital transport time, injury severity, and blood transfusion on survival of US military casualties in Iraq","volume":"85","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"9771","key":"bib6-20230825","first-page":"1096\u2013101, 101 e1","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"bib8-20230825","first-page":"298","article-title":"Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation","volume":"3","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"bib9-20230825","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/TA.0b013e318265cf87","article-title":"The immune response to surgery and trauma: implications for treatment","volume":"73","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"bib10-20230825","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1423-0127-18-90","article-title":"Molecular mechanisms of inflammation and tissue injury after major trauma\u2014is complement the \u201cbad guy\u201d?","volume":"18","year":"2011","journal-title":"J Biomed Sci"},{"issue":"12","key":"bib11-20230825","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.2011.360","article-title":"Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study","volume":"305","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"bib12-20230825","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ALN.0b013e31825f018d","article-title":"Innate immune dysfunction in trauma patients: from pathophysiology to treatment","volume":"117","year":"2012","journal-title":"Anesthesiology"},{"issue":"7285","key":"bib13-20230825","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","year":"2010","journal-title":"Nature"},{"issue":"13","key":"bib14-20230825","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A genomic storm in critically injured humans","volume":"208","year":"2011","journal-title":"J Exp Med"},{"key":"bib15-20230825","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1757-7241-17-43","article-title":"Pathophysiology of the systemic inflammatory response after major accidental trauma","volume":"17","year":"2009","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"5","key":"bib16-20230825","first-page":"190","article-title":"Induction of a hypometabolic state during critical illness - a new concept in the ICU?","volume":"68","year":"2010","journal-title":"Neth J Med"},{"issue":"2","key":"bib17-20230825","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/ACO.0000000000000047","article-title":"Inflammatory response to trauma: implications for coagulation and resuscitation","volume":"27","year":"2014","journal-title":"Curr Opin Anaesthesiol"},{"issue":"7","key":"bib18-20230825","doi-asserted-by":"crossref","first-page":"L455","DOI":"10.1152\/ajplung.00093.2013","article-title":"Protein C and acute inflammation: a clinical and biological perspective","volume":"305","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"bib19-20230825","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","year":"2001","journal-title":"N Engl J Med"},{"issue":"22","key":"bib20-20230825","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"issue":"13","key":"bib21-20230825","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa050935","article-title":"Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"bib22-20230825","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.CCM.0000089640.17523.57","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma","volume":"31","year":"2003","journal-title":"Crit Care Med"},{"issue":"5","key":"bib23-20230825","doi-asserted-by":"crossref","first-page":"L958","DOI":"10.1152\/ajplung.00359.2004","article-title":"HMGB1 contributes to the development of acute lung injury after hemorrhage","volume":"288","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"bib24-20230825","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9610(92)90099-D","article-title":"A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients","volume":"163","year":"1992","journal-title":"Am J Surg"},{"issue":"3","key":"bib25-20230825","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/SHK.0b013e31829f91fc","article-title":"Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1","volume":"40","year":"2013","journal-title":"Shock"},{"issue":"9","key":"bib26-20230825","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archsurg.1986.01400090026004","article-title":"Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation","volume":"121","year":"1986","journal-title":"Arch Surg"},{"issue":"1","key":"bib27-20230825","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/TA.0000000000000881","article-title":"Adenosine, lidocaine, and Mg2+ (ALM): from cardiac surgery to combat casualty care\u2014teaching old drugs new tricks","volume":"80","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"bib28-20230825","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/TA.0000000000000587","article-title":"Correction of acute traumatic coagulopathy with small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ occurs within 5 minutes: a ROTEM analysis","volume":"78","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib29-20230825","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/TA.0000000000001874","article-title":"Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury","volume":"84","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"11","key":"bib30-20230825","doi-asserted-by":"crossref","first-page":"e0188144","DOI":"10.1371\/journal.pone.0188144","article-title":"Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage","volume":"12","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"bib31-20230825","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1186\/cc9218","article-title":"A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients","volume":"14","year":"2010","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"bib32-20230825","first-page":"182","article-title":"Innate immunity and coagulation","volume":"9","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"bib33-20230825","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/TA.0000000000002397","article-title":"Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: a model for studying differential gene expression and extending biological time","volume":"87","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"bib34-20230825","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TA.0000000000002308","article-title":"Prehospital adenosine, lidocaine, and magnesium has inferior survival compared with tactical combat casualty care resuscitation in a porcine model of prolonged hemorrhagic shock","volume":"87","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"bib35-20230825","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1097\/CCM.0000000000000225","article-title":"Small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ has multiple benefits during hypotensive and blood resuscitation in the pig following severe blood loss: rat to pig translation","volume":"42","year":"2014","journal-title":"Crit Care Med"},{"issue":"2","key":"bib36-20230825","first-page":"e105","article-title":"Truth behind the appearances: translating new drug therapies to humans","volume":"88","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"bib37-20230825","doi-asserted-by":"crossref","first-page":"e1000014","DOI":"10.1371\/journal.pcbi.1000014","article-title":"Translational systems biology of inflammation","volume":"4","year":"2008","journal-title":"PLoS Comput Biol"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000002810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T10:18:40Z","timestamp":1692958720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000002810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":36,"journal-issue":{"issue":"2S","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000002810","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,28]]}}}